Weave Communications, Inc. WEAV
- Market cap
- $587.3M
- P/E
- 0.0×
Follow WEAV
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 13.21 | 2.91 | 4.04 | 8.10 | 5.64 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | 22.40 | 15.65 | 12.45 | 16.56 | 17.63 |
High Price
|
|||
| — | — | — | — | 907 | 889 | 806 | 844 | 854 | 904 |
Employees
|
|||
| — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | 46 | 80 | 116 | 142 | 170 | 204 | 239 |
Revenue
|
|||
| — | — | — | 59.52% | 56.88% | 57.39% | 62.51% | 68.10% | 71.40% | 72.09% |
Gross Margin
|
|||
| — | — | — | (32) | (40) | (52) | (50) | (31) | (28) | (29) |
EBT
|
|||
| — | — | — | (70.08%) | (50.59%) | (44.56%) | (34.92%) | (18.05%) | (13.78%) | (12.12%) |
EBT Margin
|
|||
| — | 0 | — | (32) | (40) | (52) | (50) | (31) | (28) | (28) |
Net Income
|
|||
| — | — | — | 10 | 16 | 22 | 27 | 25 | 27 | 30 |
Depreciation
|
|||
| — | — | — | 4.43 | 7.04 | 5.61 | 2.18 | 2.52 | 2.85 | 3.13 |
Revenue/Sh
|
|||
| — | — | — | (3.11) | (3.56) | (2.60) | (0.76) | (0.46) | (0.40) | (0.37) |
Earnings/Sh
|
|||
| — | — | — | (2.14) | (1.37) | (0.99) | (0.20) | 0.15 | 0.20 | 0.23 |
Cash Flow/Sh
|
|||
| — | — | — | (0.24) | (0.34) | (0.48) | (0.05) | (0.05) | (0.05) | (0.06) |
Capex/Sh
|
|||
| — | — | — | (2.38) | (1.71) | (1.46) | (0.24) | 0.10 | 0.14 | 0.17 |
Free CF/Sh
|
|||
| — | — | — | 6.39 | (10.03) | 5.44 | 1.28 | 1.17 | 0.93 | 1.08 |
Book Value/Sh
|
|||
| — | — | — | 10 | 11 | 21 | 65 | 68 | 72 | 76 |
Shares
|
|||
| — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | 2.50 | 2.50 | 2.70 | 2.03 | 4.58 | 5.58 | 2.42 |
PS Ratio
|
|||
| — | — | — | 0.00 | 0.00 | 2.79 | 3.46 | 9.89 | 17.03 | 7.03 |
PB Ratio
|
|||
| — | — | — | 2.36 | 2.36 | 1.75 | 1.34 | 4.04 | 5.18 | 2.15 |
EV/Sales
|
|||
| — | — | — | (12.66) | (12.66) | (6.70) | (12.03) | 105.50 | 102.14 | 39.99 |
EV/FCF
|
|||
| — | — | — | (22) | (16) | (20) | (13) | 10 | 14 | 18 |
Op' Cash Flow
|
|||
| — | — | — | (2) | (4) | (10) | (3) | (4) | (4) | (5) |
Capex
|
|||
| — | — | — | (25) | (19) | (30) | (16) | 7 | 10 | 13 |
FCF
|
|||
| — | — | — | 56 | 24 | 100 | 61 | 57 | 44 | 20 |
Working Cap'
|
|||
| — | — | — | 16 | 11 | 25 | 16 | 6 | 6 | 6 |
Total Debt
|
|||
| — | — | — | (65) | (44) | (111) | (97) | (103) | (93) | (75) |
Net Debt
|
|||
| — | — | — | 66 | (114) | 112 | 83 | 79 | 67 | 82 |
Sh' Equity
|
|||
| — | — | — | (61.65%) | (41.84%) | (38.26%) | (25.13%) | (15.16%) | (14.54%) | (14.14%) |
ROA
|
|||
| — | — | — | (1,391.34%) | 0.00% | (2,336.38%) | 0.00% | 0.00% | 0.00% | (277.34%) |
ROIC
|
|||
| — | — | — | 34.04% | 42.56% | 6,526.89% | (50.88%) | (38.27%) | (38.85%) | (37.56%) |
ROE
|
|||
Weave Communications, Inc. peers in Health Information Services
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| PHR Phreesia, Inc. | $620.7M | 59.7× | Compare |
| MDRX Veradigm Inc. | $654.5M | 0.0× | Compare |
| SOPH SOPHiA GENETICS SA | $703.2M | 0.0× | Compare |
| NRC National Research Corporation | $450.1M | 78.3× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| CARL Carlsmed, Inc. | $404.6M | 0.0× | Compare |
| EVH Evolent Health, Inc | $398.0M | 0.0× | Compare |
| CTEV Claritev Corporation | $395.9M | 0.0× | Compare |
| HSTM HealthStream, Inc. | $883.3M | 40.5× | Compare |
Weave Communications, Inc. (WEAV) key facts
- Weave Communications, Inc. (WEAV) is a Health Information Services company in the Healthcare sector, listed on the New York Stock Exchange.
- Weave Communications, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $239.0 million, up 17.0% from fiscal 2024.
- As of September 25, 2026, WEAV traded at $7.35, a market capitalization of $587.3 million.
- Return on equity was −37.6% and debt-to-equity 0.09.
Weave Communications, Inc. (WEAV) Latest News
18 Sep
Weave Communications, Inc. ranks number one in G2's Fall 2026 Patient Relationship Management Grid Report. Number one ranking in G2 grid report strengthens Weave's competitive position and customer acquisition in patient relationship management.
20 Aug
Weave Communications (WEAV) stock fair value declines as analysts align valuations with buyout terms. Buyout alignment fundamentally redefines Weave Communications' ownership and market trajectory.
Weave Communications' 2026 Pulse Survey shows healthcare practices ready for AI adoption while 60% cite ongoing data privacy concerns. Survey signals AI demand in healthcare but flags privacy issues that may temper near-term adoption of Weave solutions.
19 Aug
Weave Communications, Inc. (WEAV) was acquired for $650 million. The $650M acquisition ends WEAV's independent operations and market trajectory.
18 Aug
Weave Communications, Inc. (WEAV) announces acquisition by Francisco Partners. Acquisition by Francisco Partners constitutes a full ownership change that redefines company control, strategy and public market status.
Weave Communications stock soared today after reporting better-than-expected quarterly results and raising full-year guidance. Strong earnings beat and raised outlook signal improved financial trajectory and positive investor sentiment.
13 Aug
Weave (WEAV) released Q2 2026 earnings call transcript covering quarterly financial results, operational updates and forward guidance. Earnings call provides financial metrics and guidance that can shift near-term investor sentiment and valuation.
9 Aug
Weave Communications Q2 earnings call detailed revenue growth, customer metrics, and operational updates for the company. Q2 earnings details provide moderate financial and operational updates that may influence near-term market views.
7 Aug
Weave Communications reported record location growth in its Q2 2026 earnings call. Record location growth indicates major expansion that can significantly boost future revenue and market position.
6 Aug
Weave Communications, Inc. surpassed Q2 earnings estimates. Beating earnings estimates can drive positive short-term investor sentiment and stock gains.
Weave Communications, Inc. announced its second quarter 2026 financial results. Quarterly earnings releases typically produce moderate effects on near-term stock valuation and sentiment.
17 Jul
Weave Communications launches authorized integration with Elation Health that reduces manual workflows for primary care practices. Integration expands Weave product capabilities in primary care via Elation Health partnership.
14 Jul
Weave Communications expands its enterprise-ready platform to deliver greater security, AI-powered automation, and streamlined front-office workflows. Core platform expansion with AI automation and security upgrades strengthens enterprise positioning and revenue potential.
8 Jul
Weave Communications, Inc. ranks No. 1 in G2's Summer 2026 Patient Relationship Management Grid Report. Number one G2 ranking improves visibility and customer acquisition potential for Weave's core platform.
11 Jun
Weave Communications joins athenahealth’s Marketplace Program to equip healthcare practices with enhanced growth tools. Partnership expands Weave access to healthcare practices and supports revenue growth.
28 May
Weave launches enterprise-grade omnichannel AI receptionist built on Google Cloud’s Gemini Enterprise Agent Platform to automate healthcare front offices. AI receptionist launch with Gemini platform strengthens Weave's healthcare automation position and growth prospects.
8 May
Weave Communications (WEAV) shifts its investment narrative with upward guidance revisions signaling stronger growth and governance improvements. New guidance signaling growth and governance upgrades represent major strategic positives likely to alter WEAV's trajectory and investor sentiment.
2 May
Weave Communications (WEAV) Q1 earnings call highlights key financial results, revenue growth, profitability progress, customer metrics, and raised full-year outlook. Q1 earnings highlights detail financial performance, guidance updates, and strategic initiatives that significantly shape investor expectations and stock trajectory.
1 May
Weave Communications, Inc. Q1 2026 earnings call summary covers financial results, revenue growth, profitability metrics, and forward guidance. Quarterly earnings summaries provide key financial data and guidance that significantly shape investor expectations and stock trajectory.
Weave Communications Inc (WEAV) reported record revenue growth in Q1 2026 earnings call highlights, signaling strong financial performance and positive momentum. Record revenue growth indicates major positive shift in financial trajectory and investor sentiment for WEAV.
30 Apr
Weave Communications, Inc. (WEAV) reported Q1 earnings and revenues exceeding analyst estimates. Earnings and revenue beats signal strong financial performance, boosting investor sentiment and stock trajectory.
Weave Communications, Inc. (WEAV) announced first quarter 2026 financial results. Quarterly earnings release reveals critical financial metrics that can significantly sway investor sentiment and stock trajectory.
22 Apr
Patients delay procedures due to affordability concerns, driving rising care deferral. Weave's Call Intelligence helps healthcare providers address this by enhancing communication and conversion during calls. Call Intelligence targets key healthcare pain point of patient deferrals from costs, potentially boosting Weave's revenue in a vital sector.
17 Apr
Weave Communications launches latest platform enhancements to drive smarter growth for healthcare practices. Platform enhancements targeting healthcare enable significant growth potential and competitive positioning.
30 Mar
Minted Technology Advisors partners with Weave Communications, Inc. (WEAV) to unlock growth opportunities for healthcare practices through integrated technology solutions. Partnership enhances Weave's market reach in healthcare but impact is moderated by competitive landscape.
13 Mar
Weave Communications, Inc. (WEAV) named exclusive patient engagement platform endorsed by American Dental Association for members. Exclusive ADA endorsement delivers major credibility boost and access to vast dental market, driving customer acquisition and revenue potential.
26 Feb
Weave Communications, Inc. (WEAV) earned a top spot on G2’s 2026 Best Software Awards for Best Healthcare Software. Top ranking in G2’s Best Healthcare Software Awards bolsters WEAV's competitive positioning and investor sentiment in its core market.
24 Feb
Weave Communications, Inc. (WEAV) released highlights from its Q4 earnings call. Q4 earnings call highlights affect financial performance and market sentiment but remain balanced by broader factors.
20 Feb
Weave Communications, Inc. (WEAV) Q4 2025 earnings call highlighted financial results, revenue growth, profitability improvements, and optimistic 2026 outlook amid strong customer adoption. Q4 earnings beats, raised guidance, and strategic expansions signal major positive shifts in financial trajectory and market positioning.
Weave Communications (WEAV) stock plunged 27% on Friday after third-quarter earnings missed analyst expectations with EPS of -$0.09 versus -$0.05 forecast, revenue growth slowed to 15%, and weak Q4 guidance projected further deceleration amid competitive pressures and high churn. Missed earnings and soft guidance signal moderate headwinds to financial performance and growth trajectory but offset by core SaaS demand.